NV-HILTON
18.6.2021 15:09:10 CEST | Business Wire | Press release
After revolutionizing the Las Vegas hospitality experience decades ago, Hilton is building on its storied legacy in time for the return to travel by almost doubling its presence in the sought-after global destination over the past three years.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210618005335/en/
The company is slated to have more than 30 hotels and over 11,000 rooms across 12 brands in the market by the end of 2021. On the heels of Virgin Hotels Las Vegas, Curio Collection by Hilton’ s June opening celebration, and just weeks before the anticipated debut of Conrad Hotels & Resorts, LXR Hotels & Resorts and Hilton Hotels & Resorts at the integrated Resorts World Las Vegas complex, Hilton is making an epic return to this top-tier travel destination, bringing new premium and luxury brands to the Strip.
“Hilton helped create the Las Vegas we know today – the entertainment capital of the world grew as we invested in unparalleled hotels, dining, entertainment and design,” said Hilton President and CEO Chris Nassetta. “Now we are raising the bar again, offering brands for any style of travel with a renewed focus on premium and luxury hotels. Las Vegas has been an especially bright spot in our global growth strategy, and we are excited to open thousands of rooms there just as people begin traveling again.”
Hilton has committed to continue its expansion in the market with a pipeline of seven hotels and nearly 4,000 rooms across five brands, which will increase its footprint by more than 50% by 2023. This adds to the company’s development pipeline of more than 2,570 hotels around the world* and 105 new hotels totalling more than 16,500 rooms opened in the first quarter, along with achieving strong net unit growth of 5.8%.
Hilton has a storied history in Las Vegas with the former Las Vegas Hilton, once the largest hotel in the world and among the city’s most iconic. The hotel made Hilton the first New York Stock Exchange-listed company to enter the domestic gaming business in 1970 and the first hospitality company to have “residency” for top stars as it hosted notable entertainers including Elvis Presley for long runs. With these industry firsts, Hilton helped establish Las Vegas as the prime destination for leisure and business travel it remains today.
According to a recent survey by Hilton, nearly a quarter of Americans surveyed ranked Las Vegas at the top of their must-visit destinations. Hilton is making those travel wish lists a reality for guests, including more than 115 million Hilton Honors members globally, as it expands its presence in the market. With diverse hotel accommodations, offerings and unique amenities coupled with Hilton’s signature hospitality, the company’s growing Las Vegas properties serve every traveler for every trip occasion, backed by an award-winning guest loyalty program.
What’s new in Las Vegas:
Through a first-of-its-kind partnership, the reimagined and reconceptualized Virgin Hotels Las Vegas, Curio Collection by Hilton offers a relaxed, whimsical design and more than 1,500 chambers and suites providing a distinctly home-away-from-home personalized getaway. The resort oasis also features an exclusive spa, a five-acre pool complex including VIP-style cabanas and daybeds along with a beach club, vibrant live entertainment venues, a state-of-the-art casino and 110,000 square feet of meeting and event space. Guests can also indulge in a world-class portfolio of 12 restaurants and bars including Mediterranean dishes at Chef Todd English’s Olives, Japanese cuisine at Chef Nobu Matsuhisa’s Nobu and hand-crafted cocktails at The Shag Room.
Additionally, through a historic partnership between Hilton and Genting Group, Resorts World Las Vegas is set to open June 24 and marks the largest multi-brand deal in Hilton’s history. The $4.3 billion development integrates the largest Conrad Hotels & Resorts property in the world, one of the first LXR Hotels & Resorts locations in the U.S. and a marquee Hilton Hotels & Resorts hotel, each offering its own dedicated entrance, lobby and distinct collection of accommodations. In addition, Resorts World Las Vegas is poised to be Hilton’s largest property globally, with 3,500 guest rooms and suites. With its opening, Conrad and LXR will join Waldorf Astoria in the market to make Las Vegas the only U.S. destination housing all three of Hilton’s luxury brands. The first ground-up resort development on the Las Vegas Strip in more than a decade, the property is also conveniently near the Las Vegas Convention Center.
Guests staying at any of the three hotels can enjoy premium amenities across the Resorts World Las Vegas campus including more than 40 food and beverage outlets, seven unique pool experiences, an expansive next-generation casino floor, over 250,000 square feet of flexible meeting space and a 5,000-capacity theatre that will be home to can’t-miss performances by Celine Dion, Carrie Underwood, Katy Perry and Luke Bryan.
Other updates and recent additions to Hilton’s Las Vegas portfolio include:
- Waldorf Astoria Las Vegas – Hilton’s first and most iconic luxury brand brought a new spirit to the Strip in 2018 and continues to deliver graceful service nestled in an oasis of modern luxury and intrigue. The hotel’s award-winning spa, inviting eighth- floor pool deck and gourmet dining experiences, including high tea in the stylish Tea Lounge or craft cocktails with splendid views of the Strip at Skybar, provide unexpected moments for all who visit. An upcoming transformation of the hotel’s guestrooms, meeting space and lobby experience boasts a sleek, contemporary design with floor-to-ceiling windows that frame spectacular views of Las Vegas Boulevard and the surrounding desert landscape.
- Hampton by Hilton Las Vegas Strip South – The property opened on the south end of the Strip in December 2020 and provides easy access to the city for travelers seeking value-driven, best-in-class accommodations. The colorful hotel offers friendly service, an outdoor pool, fitness center and lounge area, along with spacious rooms, complimentary breakfast and free Wi-Fi.
- Hampton Inn & Suites by Hilton Las Vegas Convention Center / Home2 Suites by Hilton Las Vegas Convention Center – The dual-branded hotel opened in August 2020 and is conveniently located across from the Las Vegas Convention Center. The property features a bespoke “Hello LoVe” design that celebrates the vibrant, innovative spirit of Las Vegas. Both brands offer complimentary breakfast and free Wi-Fi, and Home2 Suites is pet-friendly, providing an accessible extended stay option for the whole family, pets included.
Hilton’s new and upcoming properties will make it easier than ever for Hilton Honors members to earn and redeem Points during their next trip to Las Vegas. Members who book directly through preferred Hilton channels receive exclusive benefits, discounts and rewards, access to industry-leading contactless technology through the Hilton Honors app, and hundreds of ways to earn and redeem Points on free nights, premium merchandise, charitable contributions and unique experiences.
For more information, visit https://newsroom.hilton.com/las-vegas .
About Hilton
Hilton (NYSE: HLT) is a leading global hospitality company with a portfolio of 18 world-class brands comprising more than 6,500 properties and more than one million rooms, in 119 countries and territories. Dedicated to fulfilling its founding vision to fill the earth with the light and warmth of hospitality, Hilton has welcomed more than 3 billion guests in its more than 100-year history, earned a top spot on the 2020 World’s Best Workplaces list, and was named the 2020 Global Industry Leader on the Dow Jones Sustainability Indices. In 2020, Hilton CleanStay was introduced, bringing an industry-defining standard of cleanliness and disinfection to hotels worldwide. Through the award-winning guest loyalty program Hilton Honors, the more than 115 million members who book directly with Hilton can earn Points for hotel stays and experiences money can’t buy. With the free Hilton Honors mobile app , guests can book their stay, select their room, check in, unlock their door with Digital Key and check out, all from their smartphone. Visit newsroom.hilton.com for more information, and connect with Hilton on Facebook , Twitter , LinkedIn , Instagram and YouTube .
*Numbers as of March 31, 2021.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210618005335/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
